All In Biotech

Drug Trial Radar · NCT06836557

Open Label Safety Study of Tradipitant in Idiopathic and Diabetic Gastroparesis

A Multicenter, Open Label, 3-Month Safety Study With Tradipitant in Patients With Idiopathic or Diabetic Gastroparesis

Last checked: Nov 20, 2026Latest source record: Oct 19, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingPhase 3. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

17

Actual

Start

Jan 9, 2024

Primary completion

Mar 30, 2026

Study completion Mar 30, 2026

Sponsor

Lead sponsor
Vanda PharmaceuticalsIndustry
Sponsor type
Industry
First posted
Feb 20, 2025

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 70 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is a multicenter, open label, 3-month safety study with tradipitant in patients with idiopathic and diabetic gastroparesis.

Conditions

  • Idiopathic Gastroparesis
  • Diabetic Gastroparesis
  • Gastroparesis

Interventions

  • TradipitantDrug

    BID

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Number of participants with adverse events (AEs), including suicidal ideation or behavior as measured by the C-SSRSTime frame: 12 weeks
  2. Number of participants with changes in vital signs identified as Clinically Notable Abnormal valuesTime frame: 12 weeks
  3. Number of participants with abnormal and potentially Clinically Notable Abnormal Electrocardiogram Intervals and Heart RateTime frame: 12 weeks
  4. Number of participants with Clinically Notable Abnormal laboratory valuesTime frame: 12 weeks

Locations

3 sites in 2 countries. Site status is shown where the registry gives one.

  • Vanda Investigational Site

    Leuven, Belgium

  • Vanda Investigational Site

    Liège, Belgium

  • Vanda Investigational Site

    Leipzig, Germany

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.